BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12488437)

  • 1. Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.
    Katopodis AG; Warner RG; Duthaler RO; Streiff MB; Bruelisauer A; Kretz O; Dorobek B; Persohn E; Andres H; Schweitzer A; Thoma G; Kinzy W; Quesniaux VF; Cozzi E; Davies HF; Mañez R; White D
    J Clin Invest; 2002 Dec; 110(12):1869-77. PubMed ID: 12488437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model.
    Brandl U; Michel S; Erhardt M; Brenner P; Bittmann I; Rössle M; Baschnegger H; Bauer A; Hammer C; Schmoeckel M; Reichart B
    Xenotransplantation; 2005 Mar; 12(2):134-41. PubMed ID: 15693844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo neutralization of naturally existing antibodies against linear alpha(1,3)-galactosidic carbohydrate epitopes by multivalent antigen presentation: a solution for the first hurdle of pig-to-human xenotransplantation.
    Duthaler RO; Ernst B; Fischer R; Katopodis AG; Kinzy W; Marterer W; Oehrlein R; Streiff MB; Thoma G
    Chimia (Aarau); 2010; 64(1-2):23-8. PubMed ID: 21137679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
    Zahorsky-Reeves JL; Kearns-Jonker MK; Lam TT; Jackson JR; Morris RE; Starnes VA; Cramer DV
    Xenotransplantation; 2007 Mar; 14(2):135-44. PubMed ID: 17381688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to deplete anti-Galalpha1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galalpha1-3Gal oligosaccharides.
    Mañez R; Domenech N; Centeno A; Lopez-Pelaez E; Crespo F; Juffe A; Duthaler RO; Katopodis AG
    Xenotransplantation; 2004 Sep; 11(5):408-15. PubMed ID: 15303977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914.
    Lam TT; Hausen B; Boeke-Purkis K; Paniagua R; Lau M; Hook L; Berry G; Higgins J; Duthaler RO; Katopodis AG; Robbins R; Reitz B; Borie D; Schuurman HJ; Morris RE
    Xenotransplantation; 2004 Nov; 11(6):517-24. PubMed ID: 15479461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys.
    Lam TT; Paniagua R; Shivaram G; Schuurman HJ; Borie DC; Morris RE
    Xenotransplantation; 2004 Nov; 11(6):531-5. PubMed ID: 15479463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Galalpha1-->3Gal IgM and IgG antibodies.
    Rieben R; Bovin NV; Korchagina EY; Oriol R; Nifant'ev NE; Tsvetkov DE; Daha MR; Mohacsi PJ; Joziasse DH
    Glycobiology; 2000 Feb; 10(2):141-8. PubMed ID: 10642605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Galalpha(1,3)Gal conjugate combined with hDAF preserves morphology and improves function of cardiac xenografts.
    Brandl U; Erhardt M; Michel S; Jöckle H; Burdorf L; Bittmann I; Rössle M; Mordstein V; Brenner P; Hammer C; Reichart B; Schmoeckel M
    Xenotransplantation; 2007 Jul; 14(4):323-32. PubMed ID: 17669174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous synthetic alphaGal saccharides delay hyperacute rejection following pig-to-baboon heart transplantation.
    Romano E; Neethling FA; Nilsson K; Kosanke S; Shimizu A; Magnusson S; Svensson L; Samuelsson B; Cooper DK
    Xenotransplantation; 1999 Feb; 6(1):36-42. PubMed ID: 10355731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serum level of xenoantibodies, and hDAF or alphaGAL expression on pig cells, modulate in vitro the protection given by hDAF to primate complement-mediated damage.
    Díaz TM; Mañez R; Moscoso I; López D; Santamarina I; Lopez E; Centeno A; Domenéch N
    Transplant Proc; 2005; 37(1):510-1. PubMed ID: 15808692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL.
    Zhong R; Luo Y; Yang H; Garcia B; Ghanekar A; Luke P; Chakrabarti S; Lajoie G; Phillips MJ; Katopodis AG; Duthaler RO; Cattral M; Wall W; Jevnikar A; Bailey M; Levy GA; Grant DR
    Transplantation; 2003 Jan; 75(1):10-9. PubMed ID: 12544864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha1-3 galactose trisaccharide-polyethylene glycol conjugate.
    Diamond LE; Byrne GW; Schwarz A; Davis TA; Adams DH; Logan JS
    Transplantation; 2002 Jun; 73(11):1780-7. PubMed ID: 12085001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice.
    Gock H; Salvaris E; Murray-Segal L; Mottram P; Han W; Pearse MJ; Goodman DJ; Cowan PJ; d'Apice AJ
    Xenotransplantation; 2000 Nov; 7(4):237-46. PubMed ID: 11081758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous infusion of Galalpha1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts.
    Simon PM; Neethling FA; Taniguchi S; Goode PL; Zopf D; Hancock WW; Cooper DK
    Transplantation; 1998 Feb; 65(3):346-53. PubMed ID: 9484750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
    Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
    Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of anti-Gal(alpha)1-3Gal antibody in baboons by specific alpha-Gal immunoaffinity columns.
    Kozlowski T; Ierino FL; Lambrigts D; Foley A; Andrews D; Awwad M; Monroy R; Cosimi AB; Cooper DK; Sachs DH
    Xenotransplantation; 1998 May; 5(2):122-31. PubMed ID: 9584826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy.
    Chen G; Sun H; Yang H; Kubelik D; Garcia B; Luo Y; Xiang Y; Qian A; Copeman L; Liu W; Cardella CJ; Wang W; Xiong Y; Wall W; White DJ; Zhong R
    Transplantation; 2006 Jan; 81(2):273-83. PubMed ID: 16436972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytotoxicity to pig cells and anti-alphaGal antibody level and specificity in humans and baboons.
    Neethling FA; Cooper DK
    Transplantation; 1999 Mar; 67(5):658-65. PubMed ID: 10096519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column.
    Taniguchi S; Neethling FA; Korchagina EY; Bovin N; Ye Y; Kobayashi T; Niekrasz M; Li S; Koren E; Oriol R; Cooper DK
    Transplantation; 1996 Nov; 62(10):1379-84. PubMed ID: 8958260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.